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Abstract: Some genetic diseases may have
increased cellular instability. Since chronic
myloid leukemia (CML) has a genetic base,
we aimed to seek the genetic instability of
patients by micronucleus analysis, a mutation
screening test which was applied by
cytokinesis-blocked (CB) method.
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In this study, 10 CML patients at diagnosis,
were analysed for their micronuclei (MN)
frequencies. The values were evaluated in
different culture conditions of blood and
bone marrow cells.
The results of CML patients are compared

Introduction
Countryman and Heddle proposed the human
micronucleus assay in 1976 as a faster and alternative
method to metaphase analysis (1). Micronuclei can arise
from chromosomal aberrations in a variety of cell types
besides bone marrow. So, it is important to be able to
distinguish among the mechanisms that generate
micronuclei. There are, in fact, four recognised
mechanisms by which micronuclei and micronucleus-like
structures can arise; mitotic loss of acentric fragment, a
variety of mechanical consequences of chromosomal
breakage an exchange, mitotic loss of whole
chromosomes and apopitosis. The latter is a form of
nuclear destruction in which the nucleus disintegrates and
nuclear fragments are formed (2, 3, 4, 5, 6, 7, 8, ).
The conventional micronucleus method is simple and
rapid but its full potential has not been realised because it
can not discriminate between dividing and non-dividing
cells. To visualise micronuclei the cells have to go through
mitosis. In peripheral Iymphocyte cultures it is difficult to
distinguish interphase nuclei that have undergone a
division from those that have not. The cell cycle kinetics
of Iymphocyte cultures shows variation due to both
culture conditions an differences between individuals (6).

with control’ MN values obtained by
peripheral blood cultures induced with PHA.
Between bone marrow and peripheral blood
cultures MN values with or without PHA
among patients didn’t show any significant
difference. However, when these values
compared with the control group all of them
exhibited higher MN values in a statistically
significant manner.
It is suggested that this method is useful in
the routine cytogenetic studies of leukemia.
Key Words:Micronucleus assay, cytochalasine
B, bone marrow, CML.

The 1980s heralded the development of methods to
overcome this difficulty. The most popular is the use of
cytochalasine B to block cytokinesis, which causes the
accumulation of binucleate cells at the first mitosis (9).
The micronucleus test has been generally applied to
human bone marrow red blood cells of patients treated
with anti leukemic agents (10, 11). In this study we
applied the cytokinesis-block micronucleus assay to
measure the chromosome damage in peripheral blood
and bone marrow Iymphocytes of 10 CML patients at
diagnosis before treatment.
Material and Methods
In this study two female and eight male CML patients,
between 20-71 years of age, were examined for the MN
frequency in their peripheral blood and bone marrow
samples. Control group were constituted from healthy,
non-smokers who were age and sex matched with
patients group (12, 13). For each patient three different
cell cultures were made: bone marrow culture, peripheral
blood culture with and without PHA, whereas for control
group only peripheral blood cell culture with PHA is
carried out.
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İn order to evaluate the spontaneous MN frequency,
cultures without PHA were performed both from bone
marrow and peripheral blood of patients. Their interior
control was assessed by determining the MN values from
PHA stimulated İymphocytes. Bone marrow and
peripheral blood cultures were initiated with 106 cell/ml
RPMI 1640. Cyt B were added to each culture to a final
concentration of 5µg/ml at the last 24th hour (14).

study is to determine the extent of spontaneous mutation
rate in this disease by using MN test, an index of genetic
instability, and therefore used for mutational screening
(3, 5, 6, 16, 17, 18).In addition to blood cultures with
PHA, cultures of bone marrow as well as peripheral blood
without PHA were prepared to observe this tendency of
blastic and mature cells of cases, and stabilities of normal
and transformed cells were tried to evaluate.

Bone marrow and peripheral blood Iymphocytes
cultures without PHA were harvested after 48 hours.
Peripheral Iymphocytes were harvested after 72 hours.
Routine harvesting was carried out after the culture
period. 1% solution of Trisodium Citrate was used for
mild hypotonic effect (11).

A statistically significant difference was not observed
in MN values of bone marrow and two different blood
cultures protocol of CML patients. MN values of bone
marrow were somewhat lower than that of peripheral
blood without PHA. This discrepancy, when the blastic
cells are taken into consideration, may due to age of
blasts. That is, the blasts in peripheral circulation are in
more mature stage than that of bone marrow, their
genetic instability may be higher. Stability of bone
marrow blasts may be higher because they are younger
than that of peripheral blood. Although mathematical
mean of MN values in two different milieus were
different, there was no statistical difference between
them.

At least 200 binuclear cells of each culture, that is, at
least 600 binuclear cells for each patient was evaluated
for MN. On the other hand, 500 binuclear cells were
assessed in each control culture because they were
induced with PHA.
Factors that must be taken into consideration in
evaluation are; 1-cytoplasm of binuclear cells must be
smooth and not be injured. Binuclear cells that their
cytoplasms were even became knotted in mild degree
were excluded since this type of cellls may be the fusion
of two mononuclear cells, 2-binuclear cells must not be
overlapped with other cells and with nuclei of binuclear
cells, 3-surrounding of MN must be smooth and its
diameter must not exceed 1/3 of their nuclei and its
colour must be similar to that of nucleus. AII MN’s inside
of a binuclear cell were counted.
Bone marrow as well as peripheral blood samples w/o
PHA cases were statistically considered as dependent
variable and there fore Wilcoxon test was used. Samples
and control group was also considered as independent
variable, and Mann Whitney-U test was also used.
Results
Table 1 shows the MN values of bone marrow, and of
peripheral blood samples with and without PHA. As
shown in Table 2, no statistical difference was noticed for
the results of different culture conditions of patients.
When MN values of three cultures of patients were
compared with that of control group, they were found to
be markedly higher than control (Table 3).
Discussion
It is well known that CML is a genetic disorder and has
a mutational base, as in all cancers(15). The aim of this
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Our results show that MN values of bone marrow and
peripheral blood with and without PHA were significantly
higher than that of control group (Table 3).
A few studies of MN were carried out in patient with
leukemia (10, 19, 20). One of them was realised in blood
samples with PHA of ALL patients (11). The aim of the
study was to investigate the treatment-dependent MN
values, but not the spontaneous MN values of leukemia.
It is difficult to compare our results with the mentioned
study, because of the differences of age, type of leukemia
and size of groups. The value of spontaneous MN before
treatment of six patients they obtained was 5.05% for
blood culture with PHA.
Another study about the MN values in leukemia was
carried out in bone marrow erythoblasts and MN values
of 41 cases with ours because o the difference of cells
(19) as well as study carried on cell lines by Slavotinek at
al (20).
Mean MN value of our control group was 1.30%. In
the study of Channarayappa et. al. spontaneous MN
values of peripheral blood in a healthy man who is 24
years old was found to be 0.2 (6). Migliore et al. (11) and
Scarfi et al. (21) gave 0.36 and 1.02% for the age group
of 21-33 and 1.39% for the age group of 41,54,
respectively. The MN percentages of our laboratory are
0.885±0.118 for the age group 19.8±0.66 and
1.76±0.21 for the age group 49.3±0.83.
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Table 1.

Bone marrow and peripheral blood MN values of CML patients and control group:

Patient

Bone marrow

PB without PHA

PB with PHA

CG–PB with PHA

Bi N

MN

MN(%)

Bi N

MN

MN(%)

Bi N

MN

MN(%)

Bi N

1

256

13

5.07

217

10

4.60

101

9

8.91

203

1

0.49

2

262

10

3.8

209

7

3.34

206

8

3.88

520

10

1.92

3

209

1

0.47

205

17

8.2

209

7

3.34

216

4

1.85

4

205

8

3.90

209

4

1.91

204

15

7.35

710

7

0.98

5

203

5

2.46

214

8

3.73

223

6

2.69

530

8

1.50

6

201

11

5.47

252

9

3.57

255

11

4.31

511

5

0.97

7

209

9

4.30

206

7

3.39

225

8

3.55

252

5

1.98

8

209

12

5.74

216

10

4.62

210

10

4.76

472

5

1.05

9

216

7

3.24

209

17

8.13

213

9

4.22

203

1

0.49

10

210

8

3.80

212

11

5.18

203

11

5.41

580

10

1.72

Mean±SD

218±22.5

8.4±3.53

9.4±2.55

4.84±1.92

419.7±184.63

5.6±3.2

1.30±0.57

3.83±1.55 214.9±13.63 10.00±4.19

4.67±2.05 204.9±39.65

MN

MN(%)

Bi N: Binuclear cell, MN: Micronucleus, PB: Peripheral blood, BM: Bone marrow, CG: Control group.

Table 2.

Statistical differences in comparing MN values of patients.

Patients
BM
3.83 ± 1.55
BM
3.83 ± 1.55
PB without PHA
4.67 ± 2.05

MN values (% MN)
PB without PHA
4.67 ± 2.05
PB with PHA
4.84 ± 1.92
PB with PHA
4.84 ± 1.92

Table 3.

Statistical differences in comparing MN values of patients and
control groups.

Statistical differences
Patients

Control group (%MN)

Statistical differences

BM
3.83 ± 1.55
PB without PHA
4.67±2.05
PB with PHA
4.84±1.92

PB without PHA
1.30±0.57
PB with PHA
1.30±0.57
PB with PHA
1.30±0.57

P<0.01

P>0.05
P>0.05
P>0.05

We are not aware of similar study on CML as ours
therefore these results should be tested by other
researchers and with more patients. Our results suggest
that suggested that; MN values of blastic and mature cells
in cases of CML elevated significantly than that of
peripheral blood cells in control group. These can be
taken as evidence of genetic instability in CML patients,
not only present in transformed cells but also in mature
cells of CML patients.

P<0.001
P<0.001

It can be concluded that MN analysis using CB
methodolgy sets an alternative to other mutation
screening tests like chromosomal analysis and sister
chromatid exchange. It is relatively less expensive, easy to
apply, and gives rapid results on the evaluation of higher
number of cells in a reliable way. These features render
this method useful in the routine cytogenetic studies of
leukemia.
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